On Air Now

Listen

Listen Live Now » 94.7 FM Central Wisconsin 102.9 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
37° Feels Like: 30°
Wind: N 9 mph Past 24 hrs - Precip: 0.06”
Current Radar for Zip

Tonight

Clouds Early/Clearing Late 24°

Tomorrow

Partly Cloudy 48°

Sat Night

Mostly Cloudy 28°

Alerts

Novo Nordisk says completes hemophilia drug trial

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.

Novo Nordisk said in a statement that in patients given the drug, 99 percent of bleeding episodes were treated with only one infusion and two-thirds of the patients had experienced complete resolution of bleeding.

Patients had also reported an improvement in quality of life during the trial and the drug appeared to have a safe and well-tolerated profile, Novo said in the statement.

(Reporting by Copenhagen Newsroom; Editing by Anthony Barker)

Comments